Breast, Lung Cancer Outcomes Informed by Gene Expression of Individual Infiltrating T Cells

  • Jul 3, 2018

Two studies from independent research teams have demonstrated the feasibility of teasing out gene expression patterns in tumor-infiltrating lymphocytes in breast and lung cancer, respectively, using single-cell RNA sequencing.

Read


UnitedHealth expects 150M members to be in value-based programs by 2025

  • Jul 3, 2018

UnitedHealth expects at least 150 million members will be in value-based coordinated care programs by 2025. Currently, 15 million UnitedHealthcare members across the country receive care from physicians in value-based contracts, and the insurer aims to increase that figure 10-fold over the next seven years.

Read


New Mexico Medicaid E-News

  • Jul 3, 2018

Medicaid Fee for Service – Mammogram codes Attention: Hospitals, Physicians, Laboratory and Radiology Providers Effective January, 1, 2018, New Mexico Medicaid Fee for Service replaced HCPCS codes G0202, G0204, and G0206 with CPT codes: ·         77067: SCR MAMMO BI INCL CAD ·         77066: DX MAMMO INCL CAD BI...

Read


MolDX: APC and MUTYH Gene Testing LCD – R1

  • Jul 3, 2018

LCD is revised to add CPT 81401. CPT 81401 was inadvertently left out of the draft and final LCDs.

Read


MolDX: APC and MUTYH Gene Testing LCD - R1

  • Jul 3, 2018

The following JE Local Coverage Determination (LCD) has been revised under contractor numbers 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), 01312 (NV).  Medicare Coverage Database (MCD) Number: L36882 LCD Title: MolDX: APC and MUTYH Gene Testing Effective Date: May 15, 2017 Summary of Changes: LCD is revised to add CPT 81401. CPT 81401 was inadvertently left out of the draft and...

Read


LCD ID number: L33998 (Florida/Puerto Rico/U.S. Virgin Islands)

  • Jul 3, 2018

Fulvestrant (Faslodex) -- revision to the Part A and Part B LCD Based on a local coverage determination (LCD) reconsideration request for fulvestrant (Faslodex), the “Coverage Indications, Limitations, and/or Medical Necessity” section of the LCD was revised to add the indications for uterine neoplasms, endometrial carcinoma, and uterine leiomyosarcoma. In addition, ICD-10-CM diagnosis codes C54...

Read


ACLA Statement to Senate Finance on Rural Health Care

  • Jul 3, 2018

Statement for the Record - Senate Finance Committee from the ACLA: Rural Health Care in America: Challenges and Opportunities - May 24, 2018

Read


Broader Availability of Genetic Testing a Boon for Precision Care

  • Jul 3, 2018

This approach is generating significant excitement among healthcare providers, including oncologists. In a recent survey by Cardinal Health, released in conjunction with the 2018 ASCO Annual Meeting in Chicago, more than a third of oncologists said that precision medicine will have a "significant impact" on cancer care within just two or three years.

Read